AGTX
Agentix Corp.
Key Financials
Gross Profit
$0
↓ 100.0%
Operating Income
$-513251
↑ 31.1%
Net Income
$-567048
↑ 3.1%
Revenue
$0
↓ 100.0%
EPS (Diluted)
$-0.01
0.0%
Shareholders' Equity
$-3104249.00
↓ 21.2%
Cash & Equivalents
$12369.00
↑ 8430.3%
Long-term Debt
$85000.00
↑ 70.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AGTX |
| Company Name | Agentix Corp. |
| CIK | 1603345 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | NV |
| Phone | 321-229-2014 |